TrianglePUBLICATIONS · 9779711
Topotecan for the treatment of advanced epithelial ovarian cancer: an open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 1998 Oct
- First author
- Bookman MA
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Bookman MA
- type
- Author
- name
- Malmström H
- type
- Author
- name
- Bolis G
- type
- Author
- name
- Gordon A
- type
- Author
- name
- Lissoni A
- type
- Author
- name
- Krebs JB
- type
- Author
- name
- Fields SZ
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Bookman MA
- type
- Author
- name
- Malmström H
- type
- Author
- name
- Bolis G
- type
- Author
- name
- Gordon A
- type
- Author
- name
- Lissoni A
- type
- Author
- name
- Krebs JB
- type
- Author
- name
- Fields SZ
- type
- Author
- bibliography ids
- nci-bib-25cf061db541a9ec0a40368e
- book metadata
- content sha256
- a864508584549871530a098266d55d8b64435107775fcfd8e8fda3dfa7abf730
- document type
- citation
- dois
- 10.1200/JCO.1998.16.10.3345
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:9779711
- immutable id
- pubmed:9779711@a864508584549871530a098266d55d8b64435107775fcfd8e8fda3dfa7abf730
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- Source null
- issn print
- 0732-183X
- issue
- 10
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3345-52
- volume
- 16
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 9779711
- provenance
- batch id
- 7e001e36165c25a91a06
- provider
- NCBI PubMed ESummary
- record sha256
- 9d0ab300009c5f94709d41fd02fb442b682ee98bea7fd9b1e8ac8d58def8f7d0
- response sha256
- 3515b9c50c264ae766881ea5a6c5cb10e3af8e45341fd57a5bedfa1946d08222
- retrieved at
- 2026-09-09T23:45:31.509029+00:00
- publication date
- display
- 1998 Oct
- precision
- month
- year
- 1998
- publication types
- Clinical Trial
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- source url
- https://pubmed.ncbi.nlm.nih.gov/9779711/
- title
- Topotecan for the treatment of advanced epithelial ovarian cancer: an open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel.
Preserved source evidence · Not medical advice